Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.

Moderna Crashes 17%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.·Investor's Business Daily

Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative.

Advertisement